184,069 Shares in BlackRock Health Sciences Term Trust $BMEZ Acquired by Shaker Financial Services LLC

Shaker Financial Services LLC acquired a new stake in BlackRock Health Sciences Term Trust (NYSE:BMEZ) during the third quarter, HoldingsChannel.com reports. The fund acquired 184,069 shares of the company’s stock, valued at approximately $2,654,000.

A number of other hedge funds and other institutional investors have also modified their holdings of BMEZ. Baird Financial Group Inc. purchased a new stake in shares of BlackRock Health Sciences Term Trust in the first quarter valued at about $189,000. Royal Bank of Canada increased its position in BlackRock Health Sciences Term Trust by 326.9% during the 1st quarter. Royal Bank of Canada now owns 1,594,157 shares of the company’s stock worth $23,753,000 after purchasing an additional 1,220,764 shares during the period. Bluefin Capital Management LLC acquired a new stake in shares of BlackRock Health Sciences Term Trust in the 1st quarter valued at approximately $312,000. Geneos Wealth Management Inc. purchased a new position in BlackRock Health Sciences Term Trust in the first quarter worth $40,000. Finally, Nova Wealth Management Inc. acquired a new stake in BlackRock Health Sciences Term Trust in the first quarter valued at $39,000.

BlackRock Health Sciences Term Trust Stock Up 2.1%

NYSE:BMEZ opened at $15.27 on Wednesday. The firm’s fifty day simple moving average is $15.08 and its 200-day simple moving average is $14.62. BlackRock Health Sciences Term Trust has a fifty-two week low of $12.58 and a fifty-two week high of $16.75.

BlackRock Health Sciences Term Trust Announces Dividend

The business also recently announced a monthly dividend, which will be paid on Tuesday, March 31st. Shareholders of record on Friday, March 13th will be issued a $0.11 dividend. The ex-dividend date of this dividend is Friday, March 13th. This represents a c) dividend on an annualized basis and a yield of 8.6%.

Insider Activity

In other news, Director Robert W. Fairbairn sold 10,294 shares of the business’s stock in a transaction that occurred on Thursday, December 18th. The stock was sold at an average price of $14.98, for a total transaction of $154,204.12. The sale was disclosed in a document filed with the SEC, which is available at the SEC website.

BlackRock Health Sciences Term Trust Company Profile

BlackRock Health Sciences Term Trust (NYSE: BMEZ) is a closed-end management investment company organized as a Delaware statutory trust. Launched in March 2020, BMEZ seeks to provide total return through a combination of current income and capital appreciation by investing primarily in equity and equity-related securities of companies in the health sciences sector. The trust is structured with a fixed termination date in October 2030, at which time shareholders will vote on its liquidation, extension or conversion.

The fund’s investment portfolio is diversified across subsectors within health sciences, including biotechnology, pharmaceuticals, medical devices, diagnostics and healthcare services.